Interestingly, Jønsson and coworkers reported that romidepsin was able to prevent the de novo infection of PBMCs and CD4+ T cells but not in MDMs in vitro [91] and reminded that a complete eradication is only possible by considering all latent reservoirs together. Here, CD4 is linked to infection.